title: Application of concave microwells to pancreatic tumor spheroids enabling anticancer drug evaluation in a clinically relevant drug resistance model.
abstract: Intrinsic drug resistance of pancreatic ductal adenocarcinoma (PDAC) warrants studies using models that are more clinically relevant for identifying novel resistance mechanisms as well as for drug development. Tumor spheroids (TS) mimic in vivo tumor conditions associated with multicellular resistance and represent a promising model for efficient drug screening, however, pancreatic cancer cells often fail to form spheroids using conventional methods such as liquid overlay. This study describes the induction of TS of human pancreatic cancer cells (Panc-1, Aspc-1, Capan-2) in concave polydimethylsiloxane (PDMS) microwell plates and evaluation of their usefulness as an anticancer efficacy test model. All three cell lines showed TS formation with varying degree of necrosis inside TS. Among these, Panc-1 spheroid with spherical morphology, a rather rough surface, and unique adhesion structures were successfully produced with no notable necrosis in concave microwell plates. Panc-1 TS contained growth factors or enzymes such as TGF-β1, CTGF, and MT1-MMP, and extracellular matrix proteins such as collagen type I, fibronectin, and laminin. Panc-1 cells grown as TS showed changes in stem cell populations and in expression levels of miRNAs that may play roles in chemoresistance. Visualization of drug penetration and detection of viability indicators, such as Ki-67 and MitoSOX, were optimized for TS for quantitative analysis. Water-soluble tetrazolium (MTS) and acid phosphatase (APH) assays were also successfully optimized. Overall, we demonstrated that concave PDMS microwell plates are a novel platform for preparation of TS of weakly aggregating cells and that Panc-1 spheroids may represent a novel three-dimensional model for anti-pancreatic cancer drug screening.
authors.affiliation: Lab of Onco-Pharmacology and Experimental Therapeutics, Department of Biomedical Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
authors.forename: Sang-Eun
authors.initials: SE
authors.lastname: Yeon
authors.forename: Da Yoon
authors.initials: da Y
authors.lastname: No
authors.forename: Sang-Hoon
authors.initials: SH
authors.lastname: Lee
authors.forename: Suk Woo
authors.initials: SW
authors.lastname: Nam
authors.forename: Il-Hoan
authors.initials: IH
authors.lastname: Oh
authors.forename: Jaehwi
authors.initials: J
authors.lastname: Lee
authors.forename: Hyo-Jeong
authors.initials: HJ
authors.lastname: Kuh
mesh_terms: D000969:Antinematodal Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D045744:Cell Line, Tumor; D004354:Drug Screening Assays, Antitumor / Q000295:instrumentation*; D004867:Equipment Design; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018874:Spheroids, Cellular / Q000187:drug effects* / Q000473:pathology
chemical_list: D000969:Antinematodal Agents
references.citation: Int J Cancer. 1988 Nov 15;42(5):715-20
references.pmid: 3182108
references.citation: Biochem J. 2012 Jan 15;441(2):541-52
references.pmid: 22187935
references.citation: Cancer Sci. 2008 Feb;99(2):423-31
references.pmid: 18271941
references.citation: Expert Opin Drug Discov. 2012 Sep;7(9):819-30
references.pmid: 22788761
references.citation: Int J Radiat Biol. 2007 Nov-Dec;83(11-12):849-71
references.pmid: 18058370
references.citation: Biomol Ther (Seoul). 2012 Jan;20(1):81-8
references.pmid: 24116279
references.citation: Cancer Res. 2007 Feb 1;67(3):1030-7
references.pmid: 17283135
references.citation: Biosci Rep. 2011 Feb;31(1):45-55
references.pmid: 20426768
references.citation: J Gastroenterol. 2011 Dec;46(12):1345-52
references.pmid: 22048257
references.citation: Nat Rev Cancer. 2006 Aug;6(8):583-92
references.pmid: 16862189
references.citation: Hepatology. 2013 Mar;57(3):1055-67
references.pmid: 23079745
references.citation: Pancreas. 2009 Oct;38(7):e190-9
references.pmid: 19730150
references.citation: Biotechnol J. 2008 Oct;3(9-10):1172-84
references.pmid: 18566957
references.citation: Assay Drug Dev Technol. 2010 Oct;8(5):581-90
references.pmid: 20662735
references.citation: Anticancer Res. 2007 Jan-Feb;27(1A):45-53
references.pmid: 17352215
references.citation: Clin Cancer Res. 2012 Aug 15;18(16):4234-9
references.pmid: 22711704
references.citation: Biomaterials. 2011 Nov;32(32):8087-96
references.pmid: 21813175
references.citation: Int J Colorectal Dis. 2011 Oct;26(10):1279-85
references.pmid: 21670985
references.citation: Expert Rev Anticancer Ther. 2010 Oct;10(10):1647-61
references.pmid: 20942635
references.citation: Arch Pharm Res. 2009 Jun;32(6):915-22
references.pmid: 19557370
references.citation: J Biomol Screen. 2007 Oct;12(7):925-37
references.pmid: 17942785
references.citation: PLoS One. 2013;8(2):e57250
references.pmid: 23468946
references.citation: Nat Mater. 2007 Nov;6(11):908-15
references.pmid: 17906630
references.citation: Hepatobiliary Pancreat Dis Int. 2011 Aug;10(4):428-34
references.pmid: 21813394
references.citation: J Cutan Pathol. 2011 Mar;38(3):318-9
references.pmid: 21062343
references.citation: Mol Cancer Ther. 2007 Sep;6(9):2505-14
references.pmid: 17766839
references.citation: Nat Protoc. 2009;4(3):309-24
references.pmid: 19214182
references.citation: J Natl Cancer Inst. 2006 Aug 16;98(16):1118-28
references.pmid: 16912264
references.citation: Biomaterials. 2012 Jan;33(3):837-45
references.pmid: 22054535
references.citation: Lab Chip. 2009 Jul 21;9(14):2043-9
references.pmid: 19568673
references.citation: Lab Chip. 2007 Jun;7(6):786-94
references.pmid: 17538722
references.citation: Biomaterials. 2010 May;31(15):4296-303
references.pmid: 20206991
references.citation: Nat Rev Cancer. 2009 Sep;9(9):665-74
references.pmid: 19693095
references.citation: Nat Rev Gastroenterol Hepatol. 2012 Aug;9(8):435-44
references.pmid: 22733351
references.citation: Clin Cancer Res. 2012 Aug 15;18(16):4266-76
references.pmid: 22896693
references.citation: Adv Mater. 2012 Aug 16;24(31):4271-7
references.pmid: 22740066
references.citation: Lab Chip. 2012 Jan 7;12(1):159-66
references.pmid: 22076418
references.citation: Trends Mol Med. 2011 Aug;17(8):412-23
references.pmid: 21652264
references.citation: Expert Opin Biol Ther. 2012 Oct;12(10):1347-60
references.pmid: 22784238
references.citation: PLoS One. 2009 Aug 28;4(8):e6816
references.pmid: 19714243